BDBM370225 US10233188, Example 112::US10800783, Example 112

SMILES: Cc1cc2cnc(NC3CCN(CC3)S(=O)(=O)C3CC3)nc2n([C@@H]2CCC[C@@]2(C)O)c1=O

InChI Key: InChIKey=ZGBMIKQTQVROES-XMSQKQJNSA-N

Data: 4 KI

Find this compound or compounds like it in BindingDB or PDB:

Substructure Similarity at least:  must be >=0.5 Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 4 hits for monomerid = 370225   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kcal/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
CDK2/CycE (Homo sapiens (Human))	BDBM370225 (US10233188, Example 112 | US10800783, Example 112) Show SMILES Cc1cc2cnc(NC3CCN(CC3)S(=O)(=O)C3CC3)nc2n([C@@H]2CCC[C@@]2(C)O)c1=O |r| Show InChI InChI=1S/C22H31N5O4S/c1-14-12-15-13-23-21(24-16-7-10-26(11-8-16)32(30,31)17-5-6-17)25-19(15)27(20(14)28)18-4-3-9-22(18,2)29/h12-13,16-18,29H,3-11H2,1-2H3,(H,23,24,25)/t18-,22-/m1/s1	PDB UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	0.120	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Pfizer Inc. US Patent					Assay Description The purpose of the CDK2/Cyclin E1 assay is to evaluate the inhibition (% inhibition, Kiapp and Ki values) of small molecule inhibitors by using a flu...				US Patent US10800783 (2020)
					More data for this Ligand-Target Pair
CDK2/CycE (Homo sapiens (Human))	BDBM370225 (US10233188, Example 112 | US10800783, Example 112) Show SMILES Cc1cc2cnc(NC3CCN(CC3)S(=O)(=O)C3CC3)nc2n([C@@H]2CCC[C@@]2(C)O)c1=O |r| Show InChI InChI=1S/C22H31N5O4S/c1-14-12-15-13-23-21(24-16-7-10-26(11-8-16)32(30,31)17-5-6-17)25-19(15)27(20(14)28)18-4-3-9-22(18,2)29/h12-13,16-18,29H,3-11H2,1-2H3,(H,23,24,25)/t18-,22-/m1/s1	PDB UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	0.120	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
CNRS					Assay Description The purpose of the CDK2/Cyclin E1 assay is to evaluate the inhibition (% inhibition, Kiapp and Ki values) of small molecule inhibitors by using a flu...				J Med Chem 45: 1477-86 (2002) BindingDB Entry DOI: 10.7270/Q2FX7CSG
					More data for this Ligand-Target Pair
CDK6/Cyclin D1 (Homo sapiens (Human)-Mus musculus (mouse))	BDBM370225 (US10233188, Example 112 | US10800783, Example 112) Show SMILES Cc1cc2cnc(NC3CCN(CC3)S(=O)(=O)C3CC3)nc2n([C@@H]2CCC[C@@]2(C)O)c1=O |r| Show InChI InChI=1S/C22H31N5O4S/c1-14-12-15-13-23-21(24-16-7-10-26(11-8-16)32(30,31)17-5-6-17)25-19(15)27(20(14)28)18-4-3-9-22(18,2)29/h12-13,16-18,29H,3-11H2,1-2H3,(H,23,24,25)/t18-,22-/m1/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	1.24	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Pfizer Inc. US Patent					Assay Description The purpose of the CDK6/Cyclin D1 assay is to evaluate the inhibition (% inhibition, Kiapp and Ki values) in the presence of small molecule inhibitor...				US Patent US10800783 (2020)
					More data for this Ligand-Target Pair
CDK6/Cyclin D1 (Homo sapiens (Human)-Mus musculus (mouse))	BDBM370225 (US10233188, Example 112 | US10800783, Example 112) Show SMILES Cc1cc2cnc(NC3CCN(CC3)S(=O)(=O)C3CC3)nc2n([C@@H]2CCC[C@@]2(C)O)c1=O |r| Show InChI InChI=1S/C22H31N5O4S/c1-14-12-15-13-23-21(24-16-7-10-26(11-8-16)32(30,31)17-5-6-17)25-19(15)27(20(14)28)18-4-3-9-22(18,2)29/h12-13,16-18,29H,3-11H2,1-2H3,(H,23,24,25)/t18-,22-/m1/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	1.24	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
CNRS					Assay Description The purpose of the CDK6/Cyclin D1 assay is to evaluate the inhibition (% inhibition, Kiapp and Ki values) in the presence of small molecule inhibitor...				J Med Chem 45: 1477-86 (2002) BindingDB Entry DOI: 10.7270/Q2FX7CSG
					More data for this Ligand-Target Pair